https://www.marketscreener.com/quote/stock/AYALA-PHARMACEUTICALS-INC-56593690/news/Immunome-To-Acquire-AL102-A-Phase-3-Asset-for-the-Treatment-of-Desmoid-Tumors-From-Ayala-Pharmaceu-45892716/?utm_source=telegram&utm_medium=social&utm_campaign=share